Lindsay Greenleaf Discusses the 2021 Medicare Advantage Rate and Related Effects of COVID-19

The American Journal of Managed Care® spoke with Lindsay Baylor Greenleaf, JD, MBA, Vice President of Policy, ADVI Health, about CMS’ recent enactment of the 2021 Medicare Advantage rate announcement, and the effects of COVID-19 on Medicare Advantage. This transcript has been edited slightly for clarity.

Lindsay Greenleaf Discusses the 2021 Medicare Advantage Rate and Related Effects of COVID-19

Leave a Reply

Your email address will not be published. Required fields are marked *